NF TUMOR FOUNDATION INC (EIN 222580179) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1979

Legal Domicile

Principal Officer

John Dobson

Phone

4432535383

Tax Period

2024-10-01 to 2025-09-30

NF TUMOR FOUNDATION INC, founded in 1979, is a micro nonprofit in the Diseases & Disorders sector that reported $13K in total revenue in fiscal year 2024. Revenue surged 102% from the prior year, signaling strong growth momentum. Expenses of $25K exceeded revenue, resulting in a 87% operating deficit.

Mission

Create a community of support for those affected by neurofibromatosis through education, advocacy, coalitions and promoting research for treatments and a cure. Our goal is to be the primary source of information for neurofibromatosis in the Mid-Atlantic region.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $75

Program Service Revenue $0

Investment Income $13,078

Other Revenue $0

TOTAL REVENUE $13,153

Expense Breakdown

Grants Paid $0

Salaries & Benefits $18,649

Fundraising Expenses $0

Program Expenses $18,068

Other Expenses $5,937

TOTAL EXPENSES $24,586

Year-over-Year Comparison

	2024	2023	Change
Revenue	$13,153	$6,512	+1.0%
Expenses	$24,586	$20,368	+0.2%
Net Income	$-11,433	$-13,856	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$17,150

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Ellen Stein	President	0.00	Officer Director	$0	$0	$0
Rivka Glaser	Director	0.00	Director	$0	$0	$0
Mary Louise Kolb	Director	0.00	Director	$0	$0	$0
Stephen Coonce	Director	0.00	Director	$0	$0	$0
Jessica Dobson	Director	0.00	Director	$0	$0	$0
John Dobson	Executive Director	40.00	Officer	$17,150	$0	$17,150

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$13,153	$24,586	$183,800	$-11,433
2024	$6,512	$20,368	$192,411	$-13,856
2023	$11,285	$11,707	$178,287	$-422
2022	$18,558	$15,498	$167,417	$3,060
2021	$32,191	$12,108	$194,453	$20,083
2020	$25,728	$13,922	$162,747	$11,806
2019	$38,993	$19,679	$157,627	$19,314
2018	$26,523	$20,246	$137,757	$6,277

NF TUMOR FOUNDATION INC